Related Experiment Video
Updated: May 18, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
The insulin like growth factor system in cirrhosis. Relation to changes in body composition following adrenoreceptor
Karen Bonefeld1, Lise Hobolth, Anders Juul
1Centre of Functional and Diagnostic Imaging and Research, Section of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, Denmark.
Objective:
Circulating levels of IGF-I and IGFBP-3 are low in cirrhosis and are related to liver dysfunction. Metabolic disturbances include malnutrition with altered body composition and osteopenia. Since the effects of IGF-I may be associated to changes in body composition and bone mineral content (BMC) in cirrhotic patients, we investigated the relations between changes in the IGF-system and body composition and the effects of long-term alpha- and beta-blockade.
Design:
The study was designed as a combined cross-sectional and prospective randomised controlled study of 62 patients with cirrhosis. Twenty-three of these patients were randomised to treatment with beta- or combined alpha/beta-blocker for 3 months. Haemodynamics, body composition, and systemic and hepatic IGF-I and IGFBP-3 levels were determined in all patients. In the subgroup changes in body composition and IGF-I/IGFBP-3 levels after 3 months of beta- or combined alpha/beta-blockade were additionally examined.
Results:
Both the hepatic and the systemic IGF systems were suppressed and correlated with liver dysfunction and anthropometrics (p<0.05-0.001). Multivariate analyses revealed that changes in the IGF-system were determined by metabolic liver dysfunction as well as anthropometrics. In the follow-up study, hepatic venous IGF-I (p=0.05) and IGFBP-3 (p=0.02) increased after 3 months only in the group who received beta-blocker. In both groups, fat body mass increased significantly after 3 months (p=0.05-0.001).
Conclusions:
In cirrhosis, the IGF-system is associated with both anthropometrics and synthetic capacity of the liver. Changes in IGF-I relate to changes in anthropometrics and there seems to be a differential effect depending on the type of adrenoreceptor blockade. Future longitudinal studies are needed to unravel these mechanisms in cirrhosis.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Type II Diabetes II: Pathophysiology
